Civic Intelligence

The Canary Fund

990 • Fiscal year 2023 • EIN 65-1230251

Jan 01, 2023 to Dec 31, 2023 • Filed on Oct 02, 2024

PO Box 620134Woodside, CA 94062

(650) 646-3200

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

34th percentile

0.01x

Higher debt load relative to assets than 34% of similar nonprofits.

2023 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2023

Liabilities / Revenue

28th percentile

0.01x

Higher debt load relative to revenue than 28% of similar nonprofits.

2023 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2023

Net Margin

81st percentile

28%

Higher net margin than 81% of similar nonprofits.

2023 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2023

Top Officer Pay

89th percentile

$190,500

Higher top officer pay than 89% of similar nonprofits.

Top officer pay equals 10.1% of source-year revenue.

2023 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2023

Asset Growth

87th percentile

44%

Faster asset growth than 87% of similar nonprofits.

2023 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2022 to 2023

Revenue Growth

15th percentile

-25%

Faster revenue growth than 15% of similar nonprofits.

2023 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2022 to 2023

Assets

Up

$1,687,918

Up $517,005 (+44%) from 2022

Net Assets

Up

$1,664,235

Up $538,733 (+48%) from 2022

Liabilities

Down

$23,683

Down $21,728 (-48%) from 2022

Revenue

Down

$1,883,312

Down $611,169 (-25%) from 2022

Expenses

Down

$1,352,591

Down $21,887 (-1.6%) from 2022

Net Income

Down

$530,721

Down $589,282 (-53%) from 2022

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$30M$20M$10M$0-$10MAssets 2011: $12,752,705Liabilities 2011: $12,003,219Net Assets 2011: $749,4862011Assets 2012: $15,273,665Liabilities 2012: $22,421,526Net Assets 2012: -$7,147,8612012Assets 2013: $9,626,774Liabilities 2013: $16,931,147Net Assets 2013: -$7,304,3732013Assets 2014: $13,709,562Liabilities 2014: $14,166,699Net Assets 2014: -$457,1372014Assets 2015: $10,651,818Liabilities 2015: $14,481,988Net Assets 2015: -$3,830,1702015Assets 2016: $9,262,055Liabilities 2016: $13,650,248Net Assets 2016: -$4,388,1932016Assets 2017: $3,897,958Liabilities 2017: $8,327,051Net Assets 2017: -$4,429,0932017Assets 2018: $3,575,137Liabilities 2018: $7,318,927Net Assets 2018: -$3,743,7902018Assets 2019: $6,529,556Liabilities 2019: $5,277,087Net Assets 2019: $1,252,4692019Assets 2020: $2,590,779Liabilities 2020: $2,300,334Net Assets 2020: $290,4452020Assets 2021: $632,764Liabilities 2021: $614,445Net Assets 2021: $18,3192021Assets 2022: $1,170,913Liabilities 2022: $45,411Net Assets 2022: $1,125,5022022Assets 2023: $1,687,918Liabilities 2023: $23,683Net Assets 2023: $1,664,2352023Assets 2024: $1,850,228Liabilities 2024: $115,382Net Assets 2024: $1,734,8462024

Highlighted filing

2023

Assets$1,687,918
Liabilities$23,683
Net Assets$1,664,235

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$20M$10M$0-$10MRevenue 2011: $11,795,887Expenses 2011: $3,748,507Net Income 2011: $8,047,3802011Expenses 2012: $17,836,6382012Revenue 2013: $1,879,764Expenses 2013: $2,467,782Net Income 2013: -$588,0182013Revenue 2014: $9,257,529Expenses 2014: $2,189,673Net Income 2014: $7,067,8562014Revenue 2015: $3,326,456Expenses 2015: $6,955,688Net Income 2015: -$3,629,2322015Revenue 2016: $2,222,535Expenses 2016: $3,008,557Net Income 2016: -$786,0222016Revenue 2017: $2,745,404Expenses 2017: $2,907,402Net Income 2017: -$161,9982017Revenue 2018: $3,072,122Expenses 2018: $2,446,360Net Income 2018: $625,7622018Revenue 2019: $5,877,404Expenses 2019: $838,453Net Income 2019: $5,038,9512019Revenue 2020: $2,702,998Expenses 2020: $3,809,221Net Income 2020: -$1,106,2232020Revenue 2021: $664,526Expenses 2021: $936,652Net Income 2021: -$272,1262021Revenue 2022: $2,494,481Expenses 2022: $1,374,478Net Income 2022: $1,120,0032022Revenue 2023: $1,883,312Expenses 2023: $1,352,591Net Income 2023: $530,7212023Revenue 2024: $1,792,816Expenses 2024: $1,727,013Net Income 2024: $65,8032024

Highlighted filing

2023

Revenue$1,883,312
Expenses$1,352,591
Net Income$530,721
Jump To
Filing Snapshot
Filing Period
Jan 1, 2023 to Dec 31, 2023
Signed
Oct 2, 2024
Return Version
2023v5.1
Gross Receipts
$1,883,312
Mission and Program Overview

Mission

Canary Foundation is the world's first non-profit organization dedicated solely to the funding, discovery and development of tests for early cancer detection.

Balance Sheet Detail
LineBeginningEndChange
Assets
Savings and Temporary Cash Investments$30,282$760,329▲ $730,047
Pledges and Grants Receivable$333,334$468,333▲ $134,999
Cash and Non-Interest-Bearing Accounts$445,581$292,799▼ $152,782
Land, Buildings, and Equipment, Net$28,038$46,265▲ $18,227
Prepaid Expenses and Deferred Charges$13,165$0▼ $13,165
Accounts Receivable-$0-
Other Notes and Loans Receivable, Net-$0-
Receivable From Disqualified Prsn-$0-
Receivables From Officers Etc-$0-
Investments Other Securities-$0-
Investments Program Related-$0-
Investments in Publicly Traded Securities-$0-
Intangible Assets-$0-
Inventories for Sale or Use-$0-
Total Assets$1,170,913$1,687,918▲ $517,005
Other Assets Total$320,513$120,192▼ $200,321
Liabilities
Accounts Payable and Accrued Expenses$45,411$23,683▼ $21,728
Total Liabilities$45,411$23,683▼ $21,728
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$471,655$1,085,709▲ $614,054
Net Assets With Donor Restrictions$653,847$578,526▼ $75,321
Total Net Assets Fund Balance$1,125,502$1,664,235▲ $538,733
Total Liabilities and Net Assets / Fund Balance$1,170,913$1,687,918▲ $517,005

Asset Categories

AssetBook ValueDepreciationBasis
Equipment$46,265$24,653$70,918
Other Land Buildings-$8,830$8,830
Other Assets Org$120,192--
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
Heidi AumanProgram ManagerFT$168,000$22,500$190,500

Board Members and Trustees

NameTitle
Dale JantzenDirector
Hilary ValentineDirector
Michael BallDirector
Don ListwinFounder & CEO
Kevin KennedyTreasurer
Revenue and Support

Revenue Composition

Contributions and Grants
$1,858,743
Program Service Revenue
$0
Investment Income
$24,569
Other Revenue
$0
All Other Contributions
$1,858,743
Change in Net Assets
$530,721

Noncash Contribution Practices

Property subject to holding requirements
No
Reviewed unusual noncash gifts
No
Third parties used for noncash contributions
No

Noncash Contributions

Contribution TypeContribution CountReported AmountValuation Method
Food Inventory1$96,738Fair Market Value (FMV)
Total Noncash Contributions1$96,738-
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Grants and Similar Amounts Paid$881,040
Salaries, Compensation, and Employee Benefits$245,694
Other Expenses$225,857
Total Fundraising Expense$175,840
Professional Fundraising Fees$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Grants to Domestic Orgs$854,570--$854,570
Other Salaries and Wages$113,077$33,617$6,112$152,806
Payroll Taxes$52,087$15,485$2,816$70,388
Foreign Grants$26,470--$26,470
Travel$25,374--$25,374
Pension Plan Contributions$16,650$4,950$900$22,500
Fees for Services Other--$19,301$19,301
Depreciation Depletion$10,203$936-$11,139
Insurance-$4,054-$4,054
Fees for Services Accounting-$3,416-$3,416
Other Expenses$6,690$2,660$146,711$2,660
All Other Expenses-$1,932-$1,932
Office Expenses-$536-$536
Interest-$250-$250
Information Technology$186--$186
Total Functional Expenses$1,105,307$71,444$175,840$1,352,591
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
University of WashingtonSeattle, WA-Cancer Research$563,200
Stanford School Of MedicinePalo Alto, CA-Cancer Research$106,120
Beth Israel Deaconess MedicalBoston, MA-Cancer Research$40,000
University of Texas Health CtSan Antonio, CA-Cancer Research$32,000
Urology of VirginiaVirginia Beach, VA-Cancer Research$32,000
Seattle Inst Biomedical ClinicalSeattle, WA-Cancer Research$29,600
Univ of Calif - San FranciscoSan Francisco, CA-Cancer Research$20,000
University of MichiganEast Lansing, MI-Cancer Research$18,000
Stanford UniversityStanford, CA-Cancer Research$13,650

International Summary

Spending
$26,470

International Compliance

Foreign grant records maintained
Yes
Activity in boycott countries
No
Foreign corporation ownership
No
Foreign partnership interest
No
Interest in foreign trust
No
Passive foreign investment company interest
No
Transfers to foreign corporations
No

International Activities

RegionActivityServicesOfficesEmployeesSpending
CanadaFunding of Cancer ResearchGrant00$26,470
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Insider Transactions and Loans

Loans and Receivables

Line ItemBeginningEndChange
Receivables from Disqualified Persons-$0-
Receivables from Officers, Directors, Trustees, and Key Employees-$0-
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Backup withholding compliance
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
Yes
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section A, Line 1A

In accordance with common practice in the nonprofit community, the Board delegates certain matters to The Executive Committee, which is empowered to act between board meetings if necessary, and sometimes with specifically delegated authority to act in particular areas on behalf of the full board.

Form 990, Part VI, Section A, Line 2

Board members Don Listwin (President) and Hilary Valentine (Director) are related to each other as husband and wife. Board member Don Listwin sits on the Board of directors of fellow board member Michael Ball's company.

Form 990, Part VI, Section B, Line 11B

Form 990 is prepared by an outside tax professional. The form is then reviewed by the organization's management. After a full review, the final version of the tax return is provided to all members of the organization's voting body. A representative of management authorizes the final form 990 which is then e-filed with the internal revenue service.

Form 990, Part VI, Section B, Line 12C

Members of the Board of Directors review all potential conflicts of interest periodically. Top management and all Board members are required to disclose potential conflicts and any related party affiliations. The organization seeks full transparency on all relationships. Any potential conflicts (in fact or appearance) are discussed openly and resolved in accordance with the organization's policies and procedures.

Form 990, Part VI, Section B, Line 15A

Members of the board of directors review the compensation of all high-level personnel periodically in accordance with IRS rules and regulations. Efforts are made to secure compensation data from industry sources in order to determine competitiveness and appropriateness of salaries. Every effort is made to ensure that the process is thorough and transparent in accordance with IRS guidelines and the organization's policies and procedures.

Form 990, Part VI, Section B, Line 15B

Compensation of other personnel and highly compensated employees is reviewed periodically by members of management. Efforts are made to secure compensation data from industry sources in order to determine competitiveness and appropriateness of salaries and all related benefits. All decisions are then documented in personnel files.

Form 990, Part VI, Section C, Line 18

Tax returns are available for download from several websites and by request from the organization's office in Woodside California.

Form 990, Part VI, Section C, Line 19

All of the organization's governing documents, financial statements, and other legal filings are maintained in a secure environment and held available for inspection by tax authorities and the general public. Tax returns are posted annually to our website and to www.guidestar.org (where they are available for viewing as electronic copies) and are also available by request from the organization's office.

Filing and Contact Details

Filer

Filer Name
The Canary Fund
EIN
65-1230251
Phone
6506463200
Address
PO Box 620134, Woodside, CA 94062

Signing Officer

Name
Don Listwin
Title
Founder & CEO
Phone
6506463200
Signed
2024-10-02
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Don Listwin
Formed
2004
Legal Domicile
CA
Voting Board Members
5
Independent Board Members
5
Employees
3

Preparer

Firm
Regalia & Associates Cpas
Address
103 TOWN COUNTRY DR STE K, DANVILLE, CA 94526
Preparer
Douglas W Regalia
Phone
9253140390
Supplemental Narrative

Additional Explanations

Form 990, Part III, Line 4D

OTHER PROGRAM SERVICES 4: Canary Prostate Cancer Program:The specific goals of the Canary Foundation Prostate program are to develop tests that can: 1) Identify lethal prostate cancers at an early (curable) stage; 2) Classify prostate cancers as either 1) potentially lethal; best treated with aggressive therapy b) non-lethal: suitable for continued monitoring without aggressive treatment. Given the large body of published but invalidated candidate markers for prostate cancer, we are focusing our initial efforts on evaluating the performance of a selected set of promising biomarkers. Candidate biomarkers are evaluated based on their ability to detect lethal prostate cancers at an early (curable) stage and to discriminate lethal from non-lethal prostate cancer. We are considering both fluid-based and tissue-based biomarkers for prognostic applications. The Canary Prostate Active Surveillance Study (PASS) enrolls men who opt for active surveillance of their early stage prostate cancer. Men are followed closely for signs of cancer progression, donating biospecimens and clinical data for a minimum of 5 years or until receiving treatment for their disease. The biospecimens and clinical data provide a valuable resource to test promising biomarkers and predictive tools for their use in the active surveillance setting.Canary Pancreatic Cancer Program:Canary is focused on developing diagnostics with high sensitivity and specificity to detect otherwise lethal pancreatic cancers at an early stage when they can be cured through surgical resection. We anticipate that no single biomarker will be sufficient to create a test with the required sensitivity and specificity to detect pancreatic cancer early. Instead, a definitive diagnosis will rely upon combinations of biomarkers and upon blood and imaging tests used together. To this end, the Canary pancreatic cancer researchers have collaborated to discover and validate biomarkers that will provide the basis for blood and imaging tests for the early detection of pancreatic cancer. Canary Breast Cancer Program:The breast cancer program is working to improve early detection of potentially lethal breast cancer by identifying biomarkers that complement existing imaging methods and by developing new imaging alternatives.. Breast cancer researchers are testing a modified ultrasound method to detect breast cancer at earliest stages. As such, it offers great potential in detecting tumors that are very small pinpointing the location for surgery or target therapies before the cancer has the chance to spread. Canary is committed to funding safe, efficient, cost effective tests for diagnosing cancer early.Canary Collaborations Program:Canary Foundation believes that a collaborative, coordinated approach is necessary to achieve our goals. Our multi-disciplinary, multi-institutional Early Detection Program provides a great example of this philosophy in action. Our foundation partnerships link mutual scientific expertise and entrepreneurial spirit in the hopes of advancing research in the diagnostic arena of early cancer detection. We partner with research institutions, foundations, industry and government organizations. Examples of collaborating programs include the Canary Center at Stanford, the CRUK Cambridge Centre Early Detection Programme at the University of Cambridge in England, and the Early Cancer Detection Initiative at the University of Calgary in Canada. We provide scientific program management to make sure that all funded research activities among the scientists and clinicians at the various partner institutions are on track and that any obstacles are rapidly addressed and overcome.

Form 990, Part XI, Line 9

Change in value of long-term pledges receivable = $8012

Raw XML AppendixShowing 400 of 568 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd0false
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt045411
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt023683
IRS990/AccountsReceivableGrp/EOYAmt00
IRS990/ActivitiesConductedPrtshpInd0false
IRS990/ActivityOrMissionDesc0Canary Foundation is the world's first non-profit organization dedicated solely to the funding, discovery and development of tests for early cancer detection.
IRS990/AdvertisingGrp/TotalAmt00
IRS990/AllOtherContributionsAmt01858743
IRS990/AllOtherExpensesGrp/ManagementAndGeneralAmt01932
IRS990/AllOtherExpensesGrp/TotalAmt01932
IRS990/AnnualDisclosureCoveredPrsnInd0true
IRS990/BackupWthldComplianceInd0true
IRS990/BenefitsToMembersGrp/TotalAmt00
IRS990/BooksInCareOfDetail/PersonNm0Candy Gularte-Finance Mgr
IRS990/BooksInCareOfDetail/PhoneNum06506463200
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt0PO Box 620134
IRS990/BooksInCareOfDetail/USAddress/CityNm0Woodside
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd0940629991
IRS990/BusinessRlnWith35CtrlEntInd0false
IRS990/BusinessRlnWithFamMemInd0false
IRS990/BusinessRlnWithOrgMemInd0false
IRS990/CashNonInterestBearingGrp/BOYAmt0445581
IRS990/CashNonInterestBearingGrp/EOYAmt0292799
IRS990/ChangeToOrgDocumentsInd0false
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd0false
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt00
IRS990/CompDisqualPersonsGrp/TotalAmt00
IRS990/CompensationFromOtherSrcsInd0false
IRS990/CompensationProcessCEOInd0true
IRS990/CompensationProcessOtherInd0true
IRS990/ConferencesMeetingsGrp/TotalAmt00
IRS990/ConflictOfInterestPolicyInd0true
IRS990/ConservationEasementsInd0false
IRS990/ConsolidatedAuditFinclStmtInd0false
IRS990/CreditCounselingInd0false
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt01858743
IRS990/CYGrantsAndSimilarPaidAmt0881040
IRS990/CYInvestmentIncomeAmt024569
IRS990/CYOtherExpensesAmt0225857
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt0530721
IRS990/CYSalariesCompEmpBnftPaidAmt0245694
IRS990/CYTotalExpensesAmt01352591
IRS990/CYTotalFundraisingExpenseAmt0175840
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt01883312
IRS990/DecisionsSubjectToApprovaInd0false
IRS990/DeductibleArtContributionInd0false
IRS990/DeductibleNonCashContriInd0true
IRS990/DelegationOfMgmtDutiesInd0false
IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt0936
IRS990/DepreciationDepletionGrp/ProgramServicesAmt010203
IRS990/DepreciationDepletionGrp/TotalAmt011139
IRS990/Desc0The goal of the Canary Scientific Programs is to develop blood tests and imaging tests that can together be used to detect lethal cancers at a curable stage. Our plan for early and accurate cancer detection involves first screening patients with a blood test and then moving those patients who tested positive to a high-resolution imaging test to further isolate cancer so that it can be removed. Canary Foundation is focused on five cancer types, each of which presents a significant opportunity to save lives and prevent unnecessary treatments through early detection of otherwise lethal disease: cancer of the ovary, pancreas, lung, breast and prostate. Chances of survival are highest when cancer is detected before it spreads. Thus, accurate detection of cancer that would otherwise be lethal at its earliest stage promises to dramatically improve survival after diagnosis. Canary supports early detection
IRS990/DescribedInSection501c3Ind0true
IRS990/DisregardedEntityInd0false
IRS990/DocumentRetentionPolicyInd0true
IRS990/DonorAdvisedFundInd0false
IRS990/DonorRestrictionNetAssetsGrp/BOYAmt0653847
IRS990/DonorRestrictionNetAssetsGrp/EOYAmt0578526
IRS990/DonorRstrOrQuasiEndowmentsInd0false
IRS990/ElectionOfBoardMembersInd0false
IRS990/EmployeeCnt03
IRS990/EmploymentTaxReturnsFiledInd0true
IRS990/EngagedInExcessBenefitTransInd0false
IRS990/ExpenseAmt01105307
IRS990/FamilyOrBusinessRlnInd0true
IRS990/FederalGrantAuditRequiredInd0false
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt03416
IRS990/FeesForServicesAccountingGrp/TotalAmt03416
IRS990/FeesForServicesLegalGrp/TotalAmt00
IRS990/FeesForServicesLobbyingGrp/TotalAmt00
IRS990/FeesForServicesManagementGrp/TotalAmt00
IRS990/FeesForServicesOtherGrp/FundraisingAmt019301
IRS990/FeesForServicesOtherGrp/TotalAmt019301
IRS990/FeesForServicesProfFundraising/TotalAmt00
IRS990/FeesForSrvcInvstMgmntFeesGrp/TotalAmt00
IRS990/ForeignActivitiesInd0true
IRS990/ForeignFinancialAccountInd0false
IRS990/ForeignGrantsGrp/ProgramServicesAmt026470
IRS990/ForeignGrantsGrp/TotalAmt026470
IRS990/ForeignOfficeInd0false
IRS990/Form1098CFiledInd0false
IRS990/Form8282FiledCnt00
IRS990/Form8282PropertyDisposedOfInd0false
IRS990/Form8899Filedind0false
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt00.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt10.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt20.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt30.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt40.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt50.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt040.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt18.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt24.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt34.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt44.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt54.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt022500
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/PersonNm0Heidi Auman
IRS990/Form990PartVIISectionAGrp/PersonNm1Don Listwin
IRS990/Form990PartVIISectionAGrp/PersonNm2Kevin Kennedy
IRS990/Form990PartVIISectionAGrp/PersonNm3Michael Ball
IRS990/Form990PartVIISectionAGrp/PersonNm4Dale Jantzen
IRS990/Form990PartVIISectionAGrp/PersonNm5Hilary Valentine
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt0168000
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/TitleTxt0Program Manager
IRS990/Form990PartVIISectionAGrp/TitleTxt1Founder & CEO
IRS990/Form990PartVIISectionAGrp/TitleTxt2Treasurer
IRS990/Form990PartVIISectionAGrp/TitleTxt3Director
IRS990/Form990PartVIISectionAGrp/TitleTxt4Director
IRS990/Form990PartVIISectionAGrp/TitleTxt5Director
IRS990/Form990ProvidedToGvrnBodyInd0true
IRS990/FormationYr02004
IRS990/FormerOfcrEmployeesListedInd0false
IRS990/FSAuditedInd0false
IRS990/FundraisingActivitiesInd0false
IRS990/GamingActivitiesInd0false
IRS990/GoverningBodyVotingMembersCnt05
IRS990/GrantAmt0881040
IRS990/GrantsToDomesticIndividualsGrp/TotalAmt00
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt0854570
IRS990/GrantsToDomesticOrgsGrp/TotalAmt0854570
IRS990/GrantsToIndividualsInd0false
IRS990/GrantsToOrganizationsInd0true
IRS990/GrantToRelatedPersonInd0false
IRS990/GrossReceiptsAmt01883312
IRS990/GroupReturnForAffiliatesInd0false
IRS990/IncludeFIN48FootnoteInd0false
IRS990/IncmFromInvestBondProceedsGrp/TotalRevenueColumnAmt00
IRS990/IndependentAuditFinclStmtInd0false
IRS990/IndependentVotingMemberCnt05
IRS990/IndivRcvdGreaterThan100KCnt01
IRS990/IndoorTanningServicesInd0false
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InfoInScheduleOPartXIInd0X
IRS990/InformationTechnologyGrp/ProgramServicesAmt0186
IRS990/InformationTechnologyGrp/TotalAmt0186
IRS990/InsuranceGrp/ManagementAndGeneralAmt04054
IRS990/InsuranceGrp/TotalAmt04054
IRS990/IntangibleAssetsGrp/EOYAmt00
IRS990/InterestGrp/ManagementAndGeneralAmt0250
IRS990/InterestGrp/TotalAmt0250
IRS990/InventoriesForSaleOrUseGrp/EOYAmt00
IRS990/InvestmentIncomeGrp/ExclusionAmt024569
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt024569
IRS990/InvestmentInJointVentureInd0false
IRS990/InvestmentsOtherSecuritiesGrp/EOYAmt00
IRS990/InvestmentsProgramRelatedGrp/EOYAmt00
IRS990/InvestmentsPubTradedSecGrp/EOYAmt00
IRS990/IRPDocumentCnt05
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt033483
IRS990/LandBldgEquipBasisNetGrp/BOYAmt028038
IRS990/LandBldgEquipBasisNetGrp/EOYAmt046265
IRS990/LandBldgEquipCostOrOtherBssAmt079748
IRS990/LegalDomicileStateCd0CA
IRS990/LoanOutstandingInd0false
IRS990/LobbyingActivitiesInd0false
IRS990/LocalChaptersInd0false
IRS990/MaterialDiversionOrMisuseInd0false
IRS990/MembersOrStockholdersInd0false
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd0true
IRS990/MinutesOfGoverningBodyInd0true
IRS990/MissionDesc0Canary Foundation is a public charity exempt from U.S. federal income tax under Section 501(c)(3) of the Internal Revenue Code in the United States. Canary Foundation of Canada is a Public Foundation registered with the Canada Revenue Agency; Business Number 82906 8550 RROOO1.The Canary Foundation has assembled teams of cancer researchers recognized by their peers as leaders in their disciplines from across multiple institutions and disciplines to attack the problem of early detection in a new, collaborative, action-oriented manner with the foremost objective of translating research into clinical applications. Canary differentiators include: * Dedication to early detection * Leaders in collaborative science * Focused and managed research * Best-in-class talent * 100% of donations goes to researchOne of the first decisions the Science Team made was to choose ovarian cancer as a prototype for creating an early detection blood test to detect trace amounts of proteins called biomarkers pro
IRS990/MoreThan5000KToIndividualsInd0false
IRS990/MoreThan5000KToOrgInd0true
IRS990/NetAssetsOrFundBalancesBOYAmt01125502
IRS990/NetAssetsOrFundBalancesEOYAmt01664235
IRS990/NetGainOrLossInvestmentsGrp/TotalRevenueColumnAmt00
IRS990/NetIncmFromFundraisingEvtGrp/TotalRevenueColumnAmt00
IRS990/NetIncomeFromGamingGrp/TotalRevenueColumnAmt00
IRS990/NetIncomeOrLossGrp/TotalRevenueColumnAmt00
IRS990/NetRentalIncomeOrLossGrp/TotalRevenueColumnAmt00
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt0471655
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt01085709
IRS990/NoListedPersonsCompensatedInd0X
IRS990/NoncashContributionsAmt096738
IRS990/NondeductibleContributionsInd0true
IRS990/NondeductibleContriDisclInd0true
IRS990/OccupancyGrp/TotalAmt00
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt0536
IRS990/OfficeExpensesGrp/TotalAmt0536
IRS990/OfficerMailingAddressInd0false
IRS990/OperateHospitalInd0false
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherAssetsTotalGrp/BOYAmt0320513
IRS990/OtherAssetsTotalGrp/EOYAmt0120192
IRS990/OtherChangesInNetAssetsAmt08012
IRS990/OtherEmployeeBenefitsGrp/TotalAmt00
IRS990/OtherExpensesGrp/Desc0Event & Fundraising Activities
IRS990/OtherExpensesGrp/Desc1Other Program Expenses
IRS990/OtherExpensesGrp/Desc2Website, internet, relations
IRS990/OtherExpensesGrp/Desc3Bank and credit card charges
IRS990/OtherExpensesGrp/FundraisingAmt0146711
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt03608
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt12660
IRS990/OtherExpensesGrp/ProgramServicesAmt06690
IRS990/OtherExpensesGrp/TotalAmt0146711
IRS990/OtherExpensesGrp/TotalAmt16690
IRS990/OtherExpensesGrp/TotalAmt23608
IRS990/OtherExpensesGrp/TotalAmt32660
IRS990/OtherInd0X
IRS990/OtherRevenueTotalAmt00
IRS990/OtherSalariesAndWagesGrp/FundraisingAmt06112
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt033617
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt0113077
IRS990/OtherSalariesAndWagesGrp/TotalAmt0152806
IRS990/OtherWebsiteInd0X
IRS990/OthNotesLoansReceivableNetGrp/EOYAmt00
IRS990/PartialLiquidationInd0false
IRS990/PaymentsToAffiliatesGrp/TotalAmt00
IRS990/PayPremiumsPrsnlBnftCntrctInd0false
IRS990/PayrollTaxesGrp/FundraisingAmt02816
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt015485
IRS990/PayrollTaxesGrp/ProgramServicesAmt052087
IRS990/PayrollTaxesGrp/TotalAmt070388
IRS990/PensionPlanContributionsGrp/FundraisingAmt0900
IRS990/PensionPlanContributionsGrp/ManagementAndGeneralAmt04950
IRS990/PensionPlanContributionsGrp/ProgramServicesAmt016650
IRS990/PensionPlanContributionsGrp/TotalAmt022500
IRS990/PledgesAndGrantsReceivableGrp/BOYAmt0333334
IRS990/PledgesAndGrantsReceivableGrp/EOYAmt0468333
IRS990/PoliticalCampaignActyInd0false
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt013165
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt00
IRS990/PrincipalOfficerNm0Don Listwin
IRS990/ProfessionalFundraisingInd0false
IRS990/ProgSrvcAccomActy2Grp/Desc0research programs in each of these cancer areas as well as a Collaborations Program with collaborating early detection programs and centers that include the Canary Center at Stanford for Cancer Early Detection.Canary Ovarian Cancer Program: The goal of our ovarian research program is to develop a strategy to accurately identify ovarian cancers that would otherwise be lethal at a stage when they are readily curable. Our vision is of a two-stage screening strategy, consisting of a simple blood test followed by a molecular imaging test. Development of blood and imaging tests follows a similar roadmap; both include biomarker discovery followed by validation, but they also involve different techniques and challenges.
IRS990/ProgSrvcAccomActy3Grp/Desc0Canary Lung Cancer Program:Canary is focused on developing diagnostics with high sensitivity and specificity to detect otherwise lethal lung cancers at a stage when they are readily curable. To this end, Canary has assembled a team of experts who are collaborating to discover and validate biomarkers for blood and imaging tests that together will identify individuals harboring lethal lung cancers so that they can be removed.The Canary Lung Cancer Program has supported the development and maintenance of critical biospecimen resources, blood biomarker discovery and validation, molecular imaging projects for early detection of lethal lung cancer, and epidemiology and modeling for effective lung cancer screening. (Continued on Schedule O)
IRS990/ProhibitedTaxShelterTransInd0false
IRS990/PYContributionsGrantsAmt02494411
IRS990/PYExcessBenefitTransInd0false
IRS990/PYGrantsAndSimilarPaidAmt01009000
IRS990/PYInvestmentIncomeAmt070
IRS990/PymtTravelEntrtnmntPubOfclGrp/TotalAmt00
IRS990/PYOtherExpensesAmt0129441
IRS990/PYRevenuesLessExpensesAmt01120003
IRS990/PYSalariesCompEmpBnftPaidAmt0236037
IRS990/PYTotalExpensesAmt01374478
IRS990/PYTotalRevenueAmt02494481
IRS990/QuidProQuoContributionsInd0false
IRS990/RcvblFromDisqualifiedPrsnGrp/EOYAmt00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd0false
IRS990/ReceivablesFromOfficersEtcGrp/EOYAmt00
IRS990/ReconcilationRevenueExpnssAmt0530721
IRS990/RegularMonitoringEnfrcInd0true
IRS990/RelatedEntityInd0false
IRS990/RelatedOrganizationCtrlEntInd0false
IRS990/ReportInvestmentsOtherSecInd0false
IRS990/ReportLandBuildingEquipmentInd0true
IRS990/ReportOtherAssetsInd0true
IRS990/ReportOtherLiabilitiesInd0false
IRS990/ReportProgramRelatedInvstInd0false
IRS990/RoyaltiesGrp/TotalAmt00
IRS990/RoyaltiesRevenueGrp/TotalRevenueColumnAmt00
IRS990/SavingsAndTempCashInvstGrp/BOYAmt030282
IRS990/SavingsAndTempCashInvstGrp/EOYAmt0760329
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt01858743
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt02494411
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt0834065
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt02952480
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt05998543
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt014138242
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/TotalAmt00
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt024569
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt070
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt0-126
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt04781
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt022051
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt051345
IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearMinus4YearsAmt0-174
IRS990ScheduleA/OtherIncome170Grp/TotalAmt0-174
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.52480
IRS990ScheduleA/PublicSupportPY170Pct00.53960
IRS990ScheduleA/PublicSupportTotal170Amt07447028
IRS990ScheduleA/SubstantialContributorsTotAmt06691214
IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft170Grp/TotalAmt00
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt01858743
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt02494411
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt0834065
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt02952480
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt05998543
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt014138242
IRS990ScheduleA/TotalSupportAmt014189413
IRS990ScheduleA/UnrelatedBusinessNetIncm170Grp/TotalAmt00
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd0true
IRS990ScheduleD/EquipmentGrp/BookValueAmt046265
IRS990ScheduleD/EquipmentGrp/DepreciationAmt024653
IRS990ScheduleD/EquipmentGrp/OtherCostOrOtherBasisAmt070918
IRS990ScheduleD/OtherAssetsOrgGrp/BookValueAmt0120192
IRS990ScheduleD/OtherAssetsOrgGrp/Desc0Grants and pledges receivable-long-term
IRS990ScheduleD/OtherLandBuildingsGrp/DepreciationAmt08830
IRS990ScheduleD/OtherLandBuildingsGrp/OtherCostOrOtherBasisAmt08830
IRS990ScheduleD/TotalBookValueLandBuildingsAmt046265
IRS990ScheduleD/TotalBookValueOtherAssetsAmt0120192
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt00
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt00
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt026470
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt0Canada
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt0Grant
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt0Funding of Cancer Research
IRS990ScheduleF/BoycottCountriesInd0false
IRS990ScheduleF/ForeignCorpOwnershipInd0false
IRS990ScheduleF/ForeignPartnershipInd0false
IRS990ScheduleF/GrantRecordsMaintainedInd0true
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt026470
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/PurposeOfGrantTxt0Cancer Research
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/RegionTxt0Canada
IRS990ScheduleF/InterestInForeignTrustInd0false
IRS990ScheduleF/PassiveForeignInvestmestCoInd0false
IRS990ScheduleF/SubtotalSpentAmt026470
IRS990ScheduleF/SupplementalInformationDetail/ExplanationTxt0Accrual Basis Method of Accounting
IRS990ScheduleF/SupplementalInformationDetail/FormAndLineReferenceDesc0Part II, Line 1 - Method of Accounting
IRS990ScheduleF/Total501c3OrgCnt01
IRS990ScheduleF/TotalSpentAmt026470
IRS990ScheduleF/TransferToForeignCorpInd0false
IRS990ScheduleI/GrantRecordsMaintainedInd0true
IRS990ScheduleI/RecipientTable/CashGrantAmt040000
IRS990ScheduleI/RecipientTable/CashGrantAmt129600
IRS990ScheduleI/RecipientTable/CashGrantAmt2106120
IRS990ScheduleI/RecipientTable/CashGrantAmt313650
IRS990ScheduleI/RecipientTable/CashGrantAmt420000
IRS990ScheduleI/RecipientTable/CashGrantAmt518000
IRS990ScheduleI/RecipientTable/CashGrantAmt632000
IRS990ScheduleI/RecipientTable/CashGrantAmt7563200
IRS990ScheduleI/RecipientTable/CashGrantAmt832000
IRS990ScheduleI/RecipientTable/NonCashAssistanceAmt00
IRS990ScheduleI/RecipientTable/NonCashAssistanceAmt10
IRS990ScheduleI/RecipientTable/NonCashAssistanceAmt20
IRS990ScheduleI/RecipientTable/NonCashAssistanceAmt30
IRS990ScheduleI/RecipientTable/NonCashAssistanceAmt40
IRS990ScheduleI/RecipientTable/NonCashAssistanceAmt50
IRS990ScheduleI/RecipientTable/NonCashAssistanceAmt60
IRS990ScheduleI/RecipientTable/NonCashAssistanceAmt70
IRS990ScheduleI/RecipientTable/NonCashAssistanceAmt80
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt0Cancer Research
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt1Cancer Research
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt2Cancer Research
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt3Cancer Research
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt4Cancer Research
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt5Cancer Research
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt6Cancer Research
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt7Cancer Research
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt8Cancer Research
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt0Beth Israel Deaconess Medical
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt1Seattle Inst Biomedical Clinical
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt2Stanford School Of Medicine
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt3Stanford University
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt4Univ of Calif - San Francisco
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt5University of Michigan
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt6University of Texas Health Ct
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt7University of Washington
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt8Urology of Virginia
IRS990ScheduleI/RecipientTable/RecipientEIN0042103881
IRS990ScheduleI/RecipientTable/RecipientEIN1911452438
IRS990ScheduleI/RecipientTable/RecipientEIN2946174066
IRS990ScheduleI/RecipientTable/RecipientEIN3946174066
IRS990ScheduleI/RecipientTable/RecipientEIN4381358000
IRS990ScheduleI/RecipientTable/RecipientEIN5237232618

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Facts available. Structured filing facts are available, but richer extracted sections are limited.$1.85$0.12$1.73$1.79$1.73$0.07
2023Detailed filing. Detailed filing data is available for this year.$1.69$0.02$1.66$1.88$1.35$0.53
2022Detailed filing. Detailed filing data is available for this year.$1.17$0.05$1.13$2.49$1.37$1.12
2021Detailed filing. Detailed filing data is available for this year.$0.63$0.61$0.02$0.66$0.94$0.27
2020Detailed filing. Detailed filing data is available for this year.$2.59$2.30$0.29$2.70$3.81$1.11
2019Detailed filing. Detailed filing data is available for this year.$6.53$5.28$1.25$5.88$0.84$5.04
2018Detailed filing. Detailed filing data is available for this year.$3.58$7.32$3.74$3.07$2.45$0.63
2017Detailed filing. Detailed filing data is available for this year.$3.90$8.33$4.43$2.75$2.91$0.16
2016Detailed filing. Detailed filing data is available for this year.$9.26$13.7$4.39$2.22$3.01$0.79
2015Detailed filing. Detailed filing data is available for this year.$10.7$14.5$3.83$3.33$6.96$3.63
2014Detailed filing. Detailed filing data is available for this year.$13.7$14.2$0.46$9.26$2.19$7.07
2013Detailed filing. Detailed filing data is available for this year.$9.63$16.9$7.30$1.88$2.47$0.59
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$15.3$22.4$7.15$17.8
2011Summary only. Only limited summary data is available for this year.$12.8$12.0$0.75$11.8$3.75$8.05